Isolation of a 2:1 hydrochlorothiazide-formaldehyde adduct impurity in hydrochlorothiazide drug substance by preparative chromatography and characterization by electrospray ionization LC-MS

被引:21
作者
Franolic, JD [1 ]
Lehr, GJ [1 ]
Barry, TL [1 ]
Petzinger, G [1 ]
机构
[1] US FDA, Dept Hlth & Human Serv, NE Reg Lab, Jamaica, NY 11433 USA
关键词
hydrochlorothiazide; impurities; adduct; liquid chromatography; thin-layer chromatography; electrospray ionization mass spectrometry;
D O I
10.1016/S0731-7085(01)00437-X
中图分类号
O65 [分析化学];
学科分类号
070302 [分析化学]; 081704 [应用化学];
摘要
Hydrochlorothiazide drug substance (19 lots) from five different manufacturers and four different countries of origin (USA, Italy. Hungary. and Croatia) were analyzed for the presence of impurities using a gradient elution chromatographic system, with acetonitrile-water as the mobile phase. Two known impurities of hydrochlorothiazide, 4-amino-6-chloro-1,3-benzenedisulfonamide and chlorothiazide, were separated. as well as a late-eluting, unknown, recurring impurity. The unknown impurity was isolated by preparative liquid chromatography followed by preparative thin-layer chromatography, It was characterized by electrospray ionization LC-MS as a 2:1 hydrochlorothiazide-formaldehyde adduct of the parent drug substance. The adduct is believed to form through the double condensation reaction of hydrochlorothiazide with excess formaldehyde during the parent compound's synthesis. The concentration of this impurity ranged from 0.02 to 1.1%, (area%), and was above the 0.1% USP Other Impurities threshold in 16 of the 19 lots examined. (C) 2001 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:651 / 663
页数:13
相关论文
共 23 条
[1]
[Anonymous], 1996, FED REG, V61, P372
[2]
ESTIMATION OF IMPURITY PROFILES OF DRUGS AND RELATED MATERIALS .12. ISOLATION AND IDENTIFICATION OF AN ISOMERIC IMPURITY IN DANAZOL [J].
BALOGH, G ;
CSIZER, E ;
FERENCZY, GG ;
HALMOS, Z ;
HERENYI, B ;
HORVATH, P ;
LAUKO, A ;
GOROG, S .
PHARMACEUTICAL RESEARCH, 1995, 12 (02) :295-298
[3]
Liquid chromatography mass spectrometry for the detection of platinum antineoplastic complexes [J].
Burns, RB ;
Burton, RW ;
Albon, SP ;
Embree, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1996, 14 (03) :367-372
[4]
CLAUW DJ, 1996, J RHEUMATOL S46, V23, P1
[5]
Deppeler H.P., 1981, Analytical Profiles of Drug Substances, V10, P405, DOI [10.1016/S0099-5428(08)60646-2, DOI 10.1016/S0099-5428(08)60646-2]
[6]
*FOOD DRUG ADM, 1996, GUID IND MAN PROC HO
[7]
*FOOD DRUG ADM, 1998, ANDAS IMP DRUG SUBST
[8]
ANALYSIS OF STEROIDS .43. ESTIMATION OF IMPURITY PROFILES OF DRUGS AND RELATED MATERIALS .8. COMBINED APPLICATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND NMR-SPECTROSCOPY IN THE IMPURITY PROFILING OF DRUGS [J].
GOROG, S ;
BALOGH, G ;
GAZDAG, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :829-833
[9]
*ICH STEER COMM, 1995, INT C HARM TECHN REQ
[10]
Laforce R, 1999, BIOL SIGNAL RECEPT, V8, P143